Clinical Trial Update: Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating filgrastim compared with sargramostim plus chemotherapy, peripheral stem cell transplantation, and interferon alfa in patients with m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Filgrastim (filgrastim)
• Interferon Alfa (interferon alfa)
• sargramostim (sargramostim)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: TERMINATED